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Abstract
Background: Chronic inflammation and oxidative stress play fundamental roles in the pathogenesis of non-alcoholic
steatohepatitis (NASH). Previously, we reported that myeloperoxidase (MPO), an aggressive oxidant-generating neutrophil
enzyme, is associated with NASH severity in man. We now investigated the hypothesis that MPO contributes to the
development and progression of NASH.
Methodology: Low-density lipoprotein receptor-deficient mice with an MPO-deficient hematopoietic system (LDLR2/
2/MPO2/2tp mice) were generated and compared with LDLR2/2/MPO+/+tp mice after induction of NASH by high-fat feeding.
Results: High-fat feeding caused a ,4-fold induction of liver MPO in LDLR2/2/MPO+/+ mice which was associated with
hepatic sequestration of MPO-positive neutrophils and high levels of nitrotyrosine, a marker of MPO activity. Importantly,
LDLR2/2/MPO2/2tp mice displayed markedly reduced hepatic neutrophil and T-lymphocyte infiltration (p,0.05), and strong
down regulation of pro-inflammatory genes such as TNF-a and IL-6 (p,0.05, p,0.01) in comparison with LDLR2/2/MPO+/+tp
mice. Next to the generalized reduction of inflammation, liver cholesterol accumulation was significantly diminished in
LDLR2/2/MPO2/2tp mice (p = 0.01). Moreover, MPO deficiency appeared to attenuate the development of hepatic fibrosis as
evident from reduced hydroxyproline levels (p,0.01). Interestingly, visceral adipose tissue inflammation was markedly
reduced in LDLR2/2/MPO2/2tp mice, with a complete lack of macrophage crown-like structures. In conclusion, MPO
deficiency attenuates the development of NASH and diminishes adipose tissue inflammation in response to a high fat diet,
supporting an important role for neutrophils in the pathogenesis of metabolic disease.
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Introduction
The progression of non-alcoholic steatohepatitis (NASH) is
driven by activation of the innate immune system, which
contributes to hepatocyte damage and fibrosis in various ways
[1]. Both Kupffer cells and the complement system have been
shown to be involved [2,3]. Furthermore, neutrophil accumulation
is a prominent feature of the inflammation observed in NASH
[4,5]. These phagocytes are notorious for their ability to induce
tissue damage through generation of aggressive oxidants, which is
largely mediated by the myeloperoxidase (MPO) enzyme [6,7].
Importantly, increased MPO activity has previously been suggest-
ed to promote lipid peroxidation in steatotic livers [4], a process
involved in the progression of simple steatosis to steatohepatitis.
Recently, we obtained additional evidence implicating MPO in
the progression of NASH by showing that accumulation of HOCl-
modified proteins and nitrated proteins was associated with
increased hepatic CXC chemokine expression in the liver of
patients with NASH [5]. MPO also catalyzes nitration of protein
tyrosyl groups, which is associated with human non-alcoholic fatty
liver disease (NAFLD) as well [5,8].
Next to its ability to induce tissue damage, MPO also directly
regulates inflammatory pathways and processes involved in
fibrosis. For example, MPO enhances macrophage cytotoxicity
[9] and induces neutrophil activation [10]. In addition, MPO-
derived HOCl causes fragmentation of the extracellular matrix
[11], resulting in activation of hepatic stellate cells.
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All in all, there is compelling evidence to suggest that MPO
plays a crucial role in the pathogenesis of NASH by affecting
inflammation, oxidative stress, and fibrogenesis. We now report on
studies with NASH-prone [12] low-density lipoprotein receptor-
deficient mice (LDLR2/2 mice) transplanted with MPO2/2 or
MPO+/+ bone marrow. Our data demonstrate that MPO
deficiency attenuates hepatic cholesterol accumulation, inflamma-
tion, and potentially fibrosis in response to a high-fat diet,
indicating an important role for MPO in metabolic liver disease.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Committee for Animal Welfare of
Maastricht University (Permit Number: 2007-034). The investi-
gation conforms to the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health (NIH
Publication No. 85-23, revised 1996).
Mice
Twelve weeks old female LDLR2/2 (Jackson Laboratory, Bar
Harbor, Maine) andMPO2/2 [13] orMPO+/+mice, on a C57BL/
6J background, were randomly assigned to the LDLR2/2/MPO2/
2tp (n = 9) or the LDLR2/2/MPO+/+tp (n = 9) group. LDLR2/2
mice were subjected to 11 Gy of radiation. The following day, 107
bone marrow cells of MPO2/2 and MPO+/+ mice were injected
into the tail vein of recipient LDLR2/2 mice. One LDLR2/
2/MPO+/+tp mouse did not survive after bone marrow transplan-
tation. After 10 weeks recovery, NASH was induced by feeding the
mice a diet containing 17% casein, 0.3% DL-methionine, 34%
sucrose, 14.5% cornstarch, 0.2% cholesterol, 5% cellulose, and
21% butter for 8 weeks (Scientific Animal Food and Engineering,
Villemoisson-sur-orge, France) [12]. The engraftment efficiency
was determined as previously described [14] and found to be
95.2%.To evaluate the effect of the intervention in relation to the
diet key parameters assessed in the high-fat fed mice in the current
study are compared with those obtained from chow-fed mice in a
recently published parallel experiment [15].
Tissue Specimens
Mice were sacrificed by CO2 asphyxation followed by removal
of liver and mesenteric adipose tissue. Tissues were divided into
pieces and 1) snap-frozen in liquid nitrogen for RT-PCR, ELISA,
and lipid analysis, 2) fixed with formalin and embedded in paraffin
for histopathology and immunohistochemistry, 3) snap-frozen in 2-
methylbutane after embedding in Tissue-Tek OCT (Sakura
Finetek, Zoeterwoude, the Netherlands).
Lipid Analysis
Tail vein blood was collected after 4 hours fasting in heparin
coated glass capillaries. Plasma and liver triglyceride and
cholesterol were measured using the GPO-PAP kit according to
the manufacturer’s instructions (Roche, Basel, Switzerland) after
lipid extraction was performed using a modified Folch technique
[16]. Protein content was measured by the BCA method (Pierce,
Rockford, IL).
Histology and Immunohistochemistry
Paraffin-embedded sections were cut and stained with haema-
toxylin and eosin for histopathological analysis and with Sirius red
to study collagen distribution. The degree of steatosis, lobular
inflammation, hepatocyte ballooning, and fibrosis was scored
semi-quantitatively on a 3-point scale by an experienced animal
pathologist. Frozen liver sections were immersed in Oil Red O/
isopropanol (Sigma-Aldrich, Zwijndrecht, the Netherlands) to
stain neutral lipids. Immunohistochemical staining for MPO, Ly-
6G, Mac-1, F4/80, and CD3 was performed as previously
described [5,12,14]. For quantification, six 2006 fields were
counted in a blinded fashion by two observers, and cell number
was expressed relative to the sectioned area per mm2. MPO foci
were defined as aggregation of .2 MPO-positive cells.
Quantitative Real-time PCR
Total RNA isolation, reverse transcription, and real-time PCR
was performed as previously described [5], using the primer sets
presented in Table 1. Relative gene expression was normalised
against cyclophilin A and b-actin gene expression.
Nitrotyrosine, Myeloperoxidase, and Alanine Amino
Transferase ELISA
Liver samples were homogenized with a mini-bead beater and
glass beads in lysis buffer (300 mM NaCl, 30 mM Tris-HCl
(pH 7.4), 2 mM MgCl2, 2 mM CaCl2, 1% Triton X-100, in the
presence of Pepstatin A, Leupeptin, and Aprotinin (all at 20 ng/
ml)). Plasma and liver MPO and liver nitrotyrosine were measured
using sandwich ELISA according to the manufacturer’s protocol
(Hycult Biotechnology, Uden, the Netherlands). Plasma alanine
amino transferase (ALT) was determined by ELISA (Antibodies-
online, Aachen, Germany). Samples were analysed in duplicate in
the same run. The intra-assay coefficient of variance was ,10%.
Hydroxyproline Assay
Hydroxyproline content of proteins was measured after acid
hydrolysis with 6M HCl. Amino acid analysis was performed as
recently described [17]. Briefly, samples were introduced into a
tandem mass spectrometer using UPLC. Amino acids were
measured in multiple reaction mode in ESI-positive mode. The
mass transition 131.75.85.9 was used for the identification of
hydroxyproline. Stable isotope-labelled asparagine was used as
internal standard.
Statistics
Data are represented as mean6SEM. Differences between
groups were analysed using the Mann Whitney test, or one-way
ANOVA with Dunnett’s test for multiple comparison. Statistical
analyses were performed using Graphpad Prism 5.02 for Windows
(Graphpad Software, San Diego, CA). A p value,0.05 was
considered statistically significant.
Results
Hepatic MPO Accumulation in LDLR2/2 Mice after High-
fat Feeding
Hyperlipidemic mice such as LDLR2/2 mice provide an
excellent model for the study of NASH since they uniformly
exhibit all of its phenotypic aspects, including hepatic inflamma-
tion and fibrosis, without requiring non-physiological diets
[12,14,18]. Moreover, they exhibit insulin resistance [19],
enabling mechanistic studies of NASH in the appropriate context
of metabolic aberrations as observed in humans. Previously, high-
fat feeding of these hyperlipidemic mice was shown to lead to
elevated plasma MPO levels [12,20]. We now assessed whether a
three weeks high-fat diet also affected liver MPO, using previously
described liver samples [12]. High-fat feeding caused a 3.7-fold
MPO Aggravates NASH
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increase of liver MPO protein in LDLR-deficient animals
(p,0.01; Fig. 1a). This was associated with substantial infiltration
of MPO-positive neutrophils into the liver, and not caused by
expression of MPO in Kupffer cells (Fig. 1b). These neutrophils
frequently assembled into aggregate structures around hepatocytes
with macrovesicular steatosis, resembling the crown-like macro-
phage structures found in adipose tissue of obese animals [21].
Thus, hepatic lipid accumulation triggered by a high-fat diet is
associated with liver neutrophil infiltration, leading to increased
hepatic MPO protein levels.
Reduced MPO Activity in LDLR2/2/MPO2/2tp Mice
The accumulation of MPO in the liver upon high-fat feeding
suggested that MPO might contribute to the pathogenesis of
NASH. To further examine the role of MPO in NASH, we took
advantage of the fact that MPO is exclusively expressed in the
hematopoietic system [22], and performed bone marrow trans-
plantation experiments that resulted in the generation of combined
MPO-deficient, LDL-R-deficient mice (LDLR2/2/MPO2/2tp)
mice. LDLR2/2/MPO+/+tp controls and LDLR2/2/MPO2/2tp
mice had a similar body weight, and diet-induced weight gain
was comparable (LDLR2/2/MPO+/+tp from 19.960.4 to
21.860.3 g, LDLR2/2/MPO2/2tp: from 20.060.2 to 21.960.7 g).
After high-fat feeding, MPO plasma levels in the LDLR2/
2/MPO+/+tp mice were 324 ng/ml whereas plasma from LDLR2/
2/MPO2/2tp animals contained only 22 ng/ml of MPO (p,0.01;
Fig. 2a). Similar to plasma MPO, liver MPO was very significantly
reduced in the LDLR2/2/MPO2/2tp group after high-fat feeding
as shown by quantification of MPO-positive cell numbers, with
levels well under those observed in chow-fed LDLR2/2/MPO+/+
mice(p,0.001; Fig. 2b).
To investigate if the marked reduction of hepatic MPO in
LDLR2/2/MPO2/2tp mice translated into diminished generation
of MPO-mediated cytotoxic products, we studied hepatic levels of
nitrotyrosine, a protein modification generated at sites of
inflammation as a result of the activity of several enzymes among
which MPO, which accumulates in NAFLD [5,8,23]. As expected,
mice in the LDLR2/2/MPO2/2tp group displayed significantly
reduced levels of nitrotyrosine in the liver, consistent with reduced
MPO activity (Fig. 2c; p,0.05).
Characterization of NASH Severity
Histological examination of the livers after H/E-staining
revealed diffuse microvesicular and macrovesicular steatosis in
both groups (Fig. 3). Semi-quantitative evaluation of the extent
of steatosis showed no statistically significant differences between
LDLR2/2/MPO+/+tp and LDLR2/2/MPO2/2tp mice (2.460.3 vs.
2.160.2, p= 0.43). Inflammatory cell foci were observed in both
groups, but less frequently found in the LDLR2/2/MPO2/2tp
group, although the difference was not statistically significant
(0.7560.31 vs. 0.5060.27, p= 0.12). Hepatocyte ballooning, a
feature of progressive human NASH, was not observed in either
group. Plasma levels of ALT, a marker of hepatocyte injury,
were lower in the LDLR2/2/MPO2/2tp mice (31.364.1 U/l vs.
43.263.8 U/l in LDLR2/2/MPO+/+tp mice, p,0.05).
MPO Deficiency Leads to Reduced Liver Cholesterol but
does not Affect Triglyceride Accumulation
Next, the effects of MPO deficiency on the development of
hepatic steatosis were examined in more detail. Oil red O staining
of liver sections did not reveal obvious differences with respect to
distribution or extent of lipid accumulation between LDLR2/
2/MPO+/+tp mice and LDLR2/2/MPO2/2tp mice (Fig. 4a). In line
with this, biochemical analysis revealed similar liver triglyceride
content in LDLR2/2/MPO2/2tp and LDLR2/2/MPO+/+tp animals
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(p = 0.24; Fig. 4b). Plasma triglyceride levels were also similar in
LDLR2/2/MPO+/+tp and LDLR2/2/MPO2/tp- mice (Fig. 4c). In
contrast, both plasma and hepatic cholesterol levels were
significantly lower in LDLR2/2/MPO2/2tp mice after the high-
fat diet as compared with the LDLR2/2/MPO+/+tp animals
(33.561.2 vs. 39.561.9 mM; p= 0.01, and 0.07260.005 vs.
0.09060.004 mg/mg protein; p= 0.01, respectively; Fig. 4d,e),
though cholesterol accumulation in the LDLR2/2/MPO2/2tp
group was still higher compared to LDLR2/2/MPO+/+ animals
on chow.
The differences in hepatic cholesterol do not appear to be due to
altered synthesis, since hepatic gene expression of the two master
regulators of cholesterol synthesis, SREBP1 and SREBF2, was
comparable in both groups (p = 0.89, p = 0.32, respectively;
Fig. 4f). Expression of hydroxymethylglutaryl-CoA reductase
(HMGCR), the key rate-limiting enzyme in cholesterol synthesis,
was also not significantly different (p = 0.42; Fig. 4f). Interestingly,
however, expression of SR-A and CD36, two important proteins
involved in the uptake of oxidized LDL, was lower in the LDLR2/
2/MPO2/2tp group, although the difference was only significant
for CD36 (p = 0.63, p,0.01, respectively; Fig. 4f). This may
indicate reduced internalization of oxidized cholesterol in the liver
of LDLR2/2/MPO2/2tp mice. Hepatic expression of SR-B1, a
scavenger receptor mainly involved in the uptake of HDL-derived
cholesterol and cholesteryl esters, was also decreased in LDLR2/
2/MPO2/2tp mice (p,0.01, Fig. 4f).
Figure 1. Strong high-fat diet-induced induction of MPO in the liver. A) Total liver MPO content of LDLR2/2 mice as assessed by ELISA was
almost four-fold increased by three weeks of high-fat feeding (1961 vs. 68610 ng/mg protein, p,0.01; n = 6 in both groups). B) MPO immunostaining
reveals infiltration of neutrophils into the liver of LDLR2/2 mice after three weeks of high-fat feeding (see arrows; 1006 magnification). Many
neutrophils are organized into aggregates predominantly surrounding steatotic hepatocytes (right panel; 2006 magnification). MPO was not
detected in Kupffer cells.
doi:10.1371/journal.pone.0052411.g001
Figure 2. Reduced hepatic MPO and MPO-derived nitrated proteins in LDLR2/2/MPO2/2tp mice after 8 weeks of high-fat feeding. A)
Plasma MPO levels of LDLR2/2/MPO2/2tp and LDLR2/2/MPO+/+tp mice (2267 vs. 324652 ng/ml, p,0.01). B) The MPO-positive cell number is strongly
reduced in the liver of LDLR2/2/MPO2/2tp vs. LDLR2/2/MPO+/+tp mice (49.567.6 vs. 4.061.6 cells/mm2, p,0.01), and much lower than those observed
in LDLR2/2/MPO+/+ mice on chow. C) Hepatic levels of nitrotyrosine, a marker of MPO activity, are reduced in LDLR2/2/MPO2/2tp animals in
comparison with LDLR2/2/MPO+/+tp mice (12667 vs. 14969 mmol/mg protein, p = 0.02).
doi:10.1371/journal.pone.0052411.g002
MPO Aggravates NASH
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Generalized Attenuation of High-fat Diet-induced Liver
Inflammation in LDLR2/2/MPO2/2tp Mice
Active MPO has powerful pro-inflammatory effects, partly
attributable to the generation of oxidized cholesterol [7,24].
Therefore, we next investigated the effect of MPO deficiency on
hepatic inflammation following high-fat feeding. The cellular
nature of the inflammation was investigated by immunohisto-
chemical analysis of Mac-1, Ly-6G, and CD3, markers of Kupffer
cells/macrophages, neutrophils, and T-lymphocytes, respectively.
Interestingly, the number of neutrophils and T-lymphocytes was
significantly reduced in the liver of LDLR2/2/MPO2/2tp mice
(p,0.05, p,0.05, respectively; Fig. 5a), and similar to the
numbers observed in LDLR2/2/MPO+/+ mice on chow. More-
over, additional analyses of LDLR2/2/MPO2/2tp animals consis-
tently revealed a strongly reduced expression of pro-inflammatory
genes previously implicated in the pathogenesis of NASH (Fig. 5b).
For example, tumor necrosis factor-a (TNF-a) and IL-1a mRNA
expression were almost two-fold lower in the liver of LDLR2/
2/MPO2/2tp mice compared with LDLR2/2/MPO+/+tp mice
(p,0.05, p,0.01, respectively). In addition, hepatic IL-6 expres-
sion tended to be reduced in LDLR2/2/MPO2/2tp mice relative to
LDLR2/2/MPO+/+tp mice, although the difference was not
statistically significant. Hepatic monocyte chemoattractant pro-
tein-1 (Mcp-1) mRNA expression was over two-fold lower in
LDLR2/2/MPO2/2tp mice (p,0.01), and, consistent with this,
their CD68 mRNA expression was also significantly reduced.
Taken together, these results show that MPO plays an important
role in high-fat diet-induced inflammation of the liver, promoting
both inflammatory cell recruitment and cytokine/chemokine
expression.
Reduced High-fat Diet-induced Adipose Tissue
Inflammation in LDLR2/2/MPO2/2tp Mice
The pathogenesis of NASH is mediated by cross-talk between
inflamed adipose tissue and the liver [25]. In order to investigate
the potential contribution of adipose tissue-derived factors to the
reduced hepatic inflammation in LDLR2/2/MPO2/2tp mice,
several inflammatory parameters were investigated. First of all, Ly-
6G staining revealed an absence of neutrophils in visceral adipose
tissue in both groups (data not shown). Next, visceral adipose tissue
was stained for the macrophage marker F4/80. High-fat diet-
induced obesity is characterized by infiltration of macrophages
into adipose tissue, where they organize into so-called ‘crown-like
structures’ surrounding dead adipocytes [21]. Interestingly,
adipose tissue of LDLR2/2/MPO2/2tp mice was completely
devoid of such crown-like structures, whereas they were readily
identifiable in adipose tissue of LDLR2/2/MPO+/+tp mice
(Fig. 6a). Quantitative PCR analysis of adipose tissue Mac-1
expression, another macrophage marker, was in line with these
results, showing a marked reduction in LDLR2/2/MPO2/2tp
animals (p,0.05; Fig. 6b). Similarly, expression of Mcp-1, a potent
chemo-attractant for monocytes, was strongly reduced in the
LDLR2/2/MPO2/2tp group (p,0.05; Fig. 6b). Furthermore,
adipose tissue expression of the pro-inflammatory adipokines
leptin and TNF-a was lower in LDLR2/2/MPO2/2tp animals,
whereas expression of adiponectin, which has anti-inflammatory
properties, was higher (Fig. 6c). Thus, MPO deficiency protects
adipose tissue from high-fat diet-induced inflammation, which
may contribute to the attenuation of inflammation in the liver of
LDLR2/2/MPO2/2tp mice.
Decreased Liver Fibrosis in LDLR2/2/MPO2/2tp Mice
Progression of NAFLD, mediated by sustained inflammation,
ultimately results in the development of hepatic fibrosis. Since
MPO exerts strong effects on various mechanisms involved in
fibrogenesis and has been implicated in pro-fibrotic states in
various other chronic inflammatory conditions, we next evaluated
parameters of fibrosis in the liver of LDLR2/2/MPO2/2tp and
LDLR2/2/MPO+/+tp mice. As expected in this dietary model of
NASH, Sirius red staining of collagen in liver sections indicated
only mild fibrosis in both groups (Fig. 7a). However, collagen
content appeared to be slightly decreased in LDLR2/2/MPO2/2tp
as compared to LDLR2/2/MPO+/+tp mice. More detailed quan-
titative biochemical analysis of the collagen/elastin content in liver
homogenates as determined by hydroxyproline quantity revealed a
lower amount in LDLR2/2/MPO2/2tp mice (p,0.01), supporting
that their liver was less fibrotic (Fig. 7b). This was further
substantiated by the fact that hepatic gene expression of collagen
1A1 was lower in the LDLR2/2/MPO2/2tp group (p,0.05;
Fig. 7c). Moreover, mRNA levels of PAI-1, an important regulator
of hepatic fibrosis, were significantly reduced in these animals
(p,0.01; Fig. 7c). Expression of other fibrosis-related parameters
such as tissue inhibitor of metalloproteinase 1 (TIMP1), a-smooth
muscle actin (a-SMA), MMP-13, TGF-b1, and BAMBI was also
reduced although not to a statistically significant extent (p = 0.15,
p = 0.19, p= 0.12, p = 0.06, p = 0.39, respectively); Fig. 7c).
Overall, these data suggest that MPO may promote the
progression of NAFLD towards more advanced stages with
fibrosis.
Discussion
Hepatic inflammation is one of the defining criteria in the
diagnosis of NASH, and primarily characterized by the abundant
presence of neutrophils [26]. Neutrophils are equipped with
formidable enzyme systems that generate factors with a high
potential of causing tissue damage, most prominently represented
by MPO. The results of the present study point to an important
role for MPO in the development of NASH by increasing hepatic
cholesterol accumulation, inflammation, and fibrosis.
The effect of MPO deficiency on plasma lipid levels and
inflammation was previously studied in the context of atheroscle-
rosis [20,27]. In line with our findings, plasma triglyceride levels
were comparable between LDLR2/2/MPO2/2 and LDLR2/
2/MPO+/+ mice, whereas plasma cholesterol was lower in mice
lacking MPO. We now report that hepatic cholesterol levels are
also reduced in LDLR2/2/MPO2/2tp mice after high-fat feeding.
There are several mechanisms by which MPO might affect plasma
and liver cholesterol levels. MPO is known to inhibit cholesterol
efflux from lipid-laden macrophages by oxidizing apoA-I in HDL
[28]. MPO is also able to oxidize other apolipoproteins including
Figure 3. Liver histology of LDLR2/2/MPO2/2tp animals in
comparison with LDLR2/2/MPO+/+tp mice after 8 weeks of high-
fat feeding. Representative pictures of HE-stained liver sections of
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apoB, an important component of LDL [29]. This may alter
interaction with hepatocyte receptors and contribute to dyslipide-
mia by affecting clearance. Furthermore, nitrotyrosine formation
on apoB-100 leads to enhanced uptake of cholesterol-containing
LDL by macrophages [30]. Identification of the relative impor-
tance of these mechanisms for the observed reduction of total liver
and plasma cholesterol levels will require detailed analysis of
lipoprotein profiles. In view of mounting evidence that Kupffer
Figure 4. Decreased cholesterol accumulation in the liver of LDLR2/2/MPO2/2tp mice. A) Representative Oil red O stainings of liver sections
of LDLR2/2/MPO2/2tp and LDLR2/2/MPO+/+tp mice fed a high-fat diet for 8 weeks, showing comparable lipid accumulation (1006magnification). B)
Similar hepatic triglyceride levels in LDLR2/2/MPO2/2tp and LDLR2/2/MPO+/+tp mice after high-fat feeding (0.3160.02 vs. 0.3560.02 mg/mg protein,
p = 0.24). Chow-fed LDLR2/2/MPO+/+ mice show a lower level of liver triglycerides. C) Plasma triglyceride levels are similar in LDLR2/2/MPO2/2tp and
LDLR2/2/MPO+/+tp animals after high-fat feeding (1.5060.09 vs. 1.6460.09 mmol/l, p = 0.42). D) High-fat feeding results in higher plasma cholesterol
levels in LDLR2/2/MPO+/+tp animals as compared with LDLR2/2/MPO2/2tp mice (33.560.1 vs. 39.562.0 mmol/l, p = 0.02). E) Diet-induced liver
cholesterol accumulation is reduced in LDLR2/2/MPO2/2tp mice compared with LDLR2/2/MPO+/+tp animals (0.07260.004 vs. 0.09060.004 mg/mg
protein, p = 0.01), but does not reach the level observed in chow-fed LDLR2/2/MPO+/+ mice. F) Hepatic mRNA expression of key enzymes in
cholesterol metabolism is not altered in LDLR2/2/MPO2/2tp mice, whereas scavenger receptor expression is reduced (SR-B1 1.7-fold, p,0.01; CD36
1.4-fold, p,0.01, SR-A 1.2-fold, p = 0.63).
doi:10.1371/journal.pone.0052411.g004
MPO Aggravates NASH
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cells acquire characteristics similar to lipid-laden macrophages/
foam cells in response to high-fat feeding [2,12], reduced hepatic
cholesterol in LDLR2/2/MPO2/2tp mice may be related to
diminished formation of foamy Kupffer cells.
Regardless of the mechanism, the reduced cholesterol levels in
LDLR2/2/MPO2/2tp animals are significant in light of recent data
indicating that cholesterol plays a pivotal role in the induction of
inflammation in NASH [12,31]. In this context, scavenging of
oxidized cholesterol/lipoprotein particles by Kupffer cells and
hepatocytes may be an initiating factor. Uptake of oxidized LDL/
HDL is mediated by scavenger receptors, and is associated with
chronic inflammation [32]. Of note, scavenger receptor expression
is regulated by oxidized LDL through a positive feedback loop
[33]. The reduced expression of CD36 that we found in the liver
of LDLR2/2/MPO2/2tp mice may therefore be indicative of lower
oxidized LDL levels, consistent with lower MPO activity. Future
studies on the levels of oxidized cholesterol in plasma and liver are
required to further define the mechanisms involved.
In addition to the pro-inflammatory effects related to cholesterol
accumulation and modification, MPO can promote inflammation
in various other ways. Firstly, MPO-mediated generation of HOCl
and NO2 radicals directly results in chlorination and nitration of
proteins and nucleic acids [7] reflecting cellular damage, a potent
inducer of inflammation. The fact that hepatic nitrotyrosine levels
were lower in LDLR2/2/MPO2/2tp mice suggests that MPO-
mediated protein nitration may indeed contribute to high-fat diet-
induced hepatic inflammation. Secondly, MPO and MPO-derived
HOCl activate NF-kB signalling and increase TNF-a production
by macrophages and other leukocytes [9,10,34]. This is consistent
with our observation of lower hepatic and adipose tissue TNF-a
expression in the LDLR2/2/MPO2/2tp mice, and may be related
to an interaction between neutrophil-derived MPO and hepatic
macrophages. Importantly, pro-inflammatory TNF-a and NF-kB
signalling are key factors in the progression of NAFLD [1].
Thirdly, MPO activity is linked to lipid peroxidation, which is a
prominent characteristic of fatty livers, promoting activation of
stellate cells and attraction of inflammatory cells [35,36]. Indeed,
the substantial reduction of hepatic neutrophils and T-lympho-
cytes in LDLR2/2/MPO2/2tp mice provides supporting evidence
for an important role of MPO-mediated lipid peroxidation in
chemo-attraction of leukocytes in NASH.
Interestingly, we observed reduced numbers of adipose tissue
macrophages in LDLR2/2/MPO2/2tp mice. This is in line with
recent data indicating that high-fat diet-induced infiltration of
macrophages into adipose tissue is preceded by neutrophil
infiltration [37]. Moreover, lipid peroxidation is known to be
markedly elevated in adipose tissue of obese mice [38]. Hence, our
findings suggest that the reported early diet-induced sequestration
Figure 5. General reduction of diet-induced hepatic inflammation in LDLR2/2/MPO2/2tp mice. A) Significantly lower number of hepatic Ly-
6G+ neutrophils and CD3+ T-lymphocytes in LDLR2/2/MPO2/2tp mice as compared with LDLR2/2/MPO+/+tp mice after 8 weeks of high-fat feeding (Ly-
6G: 36.762.6 vs. 47.863.1 cells/mm2, p = 0.03; CD3: 49.164.2 vs. 62.965.0 cells/mm2, p = 0.04). Pictures represent examples of the stainings (2006
magnification). B) Hepatic pro-inflammatory cytokine/chemokine expression is substantially reduced in LDLR2/2/MPO2/2tp mice after 8 weeks high-
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of neutrophils in adipose tissue may promote lipid peroxidation via
MPO-dependent mechanisms. Furthermore, accumulation of
oxidized lipids in adipose tissue is associated with dysregulated
adipokine expression [38], which is in line with our data on leptin
and adiponectin expression. Importantly, reduced adiponectin and
increased leptin secretion by adipose tissue promotes lipid
accumulation, inflammation, and fibrogenesis in the liver [39].
Next to dysregulated adiponectin and leptin expression,
numerous other factors modulated by MPO and MPO-derived
products affect the development of fibrosis. For example, MPO-
generated oxidants activate matrix metalloproteinases [40] while
inhibiting protease inhibitors such as TIMP1 [41]. These actions
are thought to suppress fibrosis. In contrast, high levels of MPO-
derived HOCl can also inactivate matrix metalloproteinase 7 [42],
thereby promoting fibrosis. Furthermore, MPO-related lipid
peroxidation products stimulate stellate cell synthesis of type I
collagen, the major collagen of the fibrotic liver [43], which
expression was significantly reduced in the LDLR2/2/MPO2/2tp
mice. Finally, HOCl fragments the extracellular matrix [11],
which is associated with stellate cell activation as well. Our data
indicate that in vivo, the pro-fibrotic effects of MPO may outweigh
anti-fibrotic processes in the context of NASH, even though the
fibrosis we observed was still very mild.
Our findings are likely to be clinically important since human
NAFLD is associated with high numbers of MPO-expressing cells
and accumulation of HOCl-modified and nitrated proteins [4,5,8].
Furthermore, there is strong evidence for increased oxidative stress
and extensive lipid peroxidation in human NASH [4,36,44]. In
this regard it is also important to note that in comparison to the
mouse, human blood contains 5–7 times more neutrophils with a
longer half-life, each containing about 10-fold more MPO [6,45].
As such, it is likely that the contribution of MPO to the progression
of NAFLD in man is more pronounced. Moreover, high and
sustained MPO activity results in oxidative DNA damage [46],
which is associated with the ultimate and most devastating
complication of NASH, hepatocellular carcinoma [36].
In conclusion, we have shown that MPO-deficiency diminishes
high-fat diet-induced NASH by reducing hepatic cholesterol
accumulation, inflammation, and fibrosis. Furthermore, our data
indicate a general role for MPO in the chronic inflammation
associated with obesity and insulin resistance, and therefore argue
Figure 6. Reduced diet-induced adipose tissue inflammation in LDLR2/2/MPO2/2tp mice. A) Lack of high-fat diet-associated macrophage
‘crown-like structures’ in visceral adipose tissue of LDLR2/2/MPO2/2tp mice as revealed by F4/80 immunostaining (2006magnification). B) Adipose
tissue mRNA expression of the macrophage marker Mac-1 and the macrophage chemokine Mcp-1 is significantly lower in LDLR2/2/MPO2/2tp mice
fed a high-fat diet for 8 weeks (p,0.05). C) Reduced adipose tissue expression of the adipokines leptin and TNF-a in LDLR2/2/MPO2/2tp mice after 8
weeks of high-fat feeding, whereas expression of adiponectin is increased.
doi:10.1371/journal.pone.0052411.g006
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for a re-evaluation of the role of neutrophils and their cytotoxic
products in the pathogenesis of metabolic disease.
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